Task order title: preventing colorectal cancer using trail-inducing ONC201 alone or in combination with nsaid
Ended Awarded Last action
- Contract number
- 75N91020F00004
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $878,817
Award facts
- Opportunity
- Contract value 100% obligated
- $878,817.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73126, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$648 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $879,465 |
About this award
This is a delivery order award under the National Cancer Institute's PREVENT Preclinical Drug Development Program, a $149,995,000 indefinite-delivery, indefinite-quantity (IDIQ) contract. The award, valued at $878,817.03, is for a task order titled "Preventing Colorectal Cancer Using TRAIL-Inducing ONC201 Alone or in Combination with NSAID." The prime contractor is the University of Oklahoma Health Sciences Center, a state-funded public research university with significant federal research experience. The award does not have a set-aside designation. This task order is part of the PREVENT program, which supports the evaluation of potential cancer preventive agents through preclinical product development, manufacturing, and toxicology testing.
Quick answers
Who was awarded contract 75N91020F00004?
75N91020F00004 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 15, 2020.
How much is contract 75N91020F00004 worth?
The government has obligated $878,817 on 75N91020F00004.
Is contract 75N91020F00004 an order under another contract?
Yes. 75N91020F00004 is a delivery order under 75N91019D00020, an indefinite delivery contract, on PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91020F00004 competed?
The extent of competition for 75N91020F00004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award